Essilor International Compagnie Generale d’Optique SA (EI):企業の財務・戦略的SWOT分析

◆英語タイトル:Essilor International Compagnie Generale d'Optique SA (EI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C3380
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Essilor International Compagnie Generale d’Optique SA (EI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Essilor International Compagnie Generale d’Optique SA (Essilor) designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatism. It also manufactures and sells non-prescription reading glasses, sunglasses, equipment, instruments and consumables used by prescription laboratories and eyecare professionals. Essilor has manufacturing facilities across North America, Latin America, Europe and Asia Middle East, Russia and Africa (AMERA). The company sells its products through a network of distributors in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Essilor is headquartered in Paris, France.

Essilor International Compagnie Generale d’Optique SA Key Recent Developments

Jul 26,2018: Essilor: First-Half 2018 results strong second quarter delivering on the growth strategy
Jul 26,2018: Proposed combination between Essilor and Luxottica approved in China
Jun 21,2018: Essilor moves up in Forbes World’s 100 Most Innovative Companies annual ranking
May 29,2018: Essilor partners with the Government of Odisha to launch livelihood building programme, Eye Mitra
Apr 24,2018: Essilor announces changes in Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Essilor International Compagnie Generale d’Optique SA – Key Facts 6
Essilor International Compagnie Generale d’Optique SA – Key Employees 7
Essilor International Compagnie Generale d’Optique SA – Key Employee Biographies 8
Essilor International Compagnie Generale d’Optique SA – Major Products and Services 9
Essilor International Compagnie Generale d’Optique SA – History 11
Essilor International Compagnie Generale d’Optique SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 22
Section 2 – Company Analysis 23
Company Overview 23
Essilor International Compagnie Generale d’Optique SA – Business Description 24
Business Segment: Equipment 24
Overview 24
Performance 24
Business Segment: Lenses & Optical Instruments 24
Overview 24
Performance 24
Business Segment: Sunglasses & Readers 25
Overview 25
Performance 25
Geographical Segment: Asia, Oceania, Africa 25
Performance 25
Geographical Segment: Europe 25
Performance 25
Geographical Segment: Latin America 25
Performance 25
Geographical Segment: North America 26
Performance 26
R&D Overview 26
Essilor International Compagnie Generale d’Optique SA – Corporate Strategy 27
Essilor International Compagnie Generale d’Optique SA – SWOT Analysis 28
SWOT Analysis – Overview 28
Essilor International Compagnie Generale d’Optique SA – Strengths 28
Essilor International Compagnie Generale d’Optique SA – Weaknesses 29
Essilor International Compagnie Generale d’Optique SA – Opportunities 30
Essilor International Compagnie Generale d’Optique SA – Threats 31
Essilor International Compagnie Generale d’Optique SA – Key Competitors 32
Section 3 – Company Financial Ratios 33
Financial Ratios – Capital Market Ratios 33
Financial Ratios – Annual Ratios 34
Performance Chart 37
Financial Performance 37
Financial Ratios – Interim Ratios 38
Financial Ratios – Ratio Charts 39
Section 4 – Company’s Lifesciences Financial Deals and Alliances 40
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 40
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deals By Type, 2012 to YTD 2018 41
Essilor International Compagnie Generale d’Optique SA, Recent Deals Summary 42
Section 5 – Company’s Recent Developments 43
Jul 26, 2018: Essilor: First-Half 2018 results strong second quarter delivering on the growth strategy 43
Jul 26, 2018: Proposed combination between Essilor and Luxottica approved in China 44
Jun 21, 2018: Essilor moves up in Forbes World’s 100 Most Innovative Companies annual ranking 45
May 29, 2018: Essilor partners with the Government of Odisha to launch livelihood building programme, Eye Mitra 46
Apr 27, 2018: Essilor: First Quarter Driving Toward Full-Year Targets 47
Apr 24, 2018: Essilor announces changes in Board of Directors 49
Apr 16, 2018: Essilor to put proven expertise of vision care capacity-building at the service of the Commonwealth 50
Mar 01, 2018: Essilor to allocate exceptional French tax refund to the Group’s initiatives to eradicate poor vision 51
Mar 01, 2018: Proposed combination between Essilor and Luxotticareceives clearance from US Federal Trade Commission without conditions 52
Mar 01, 2018: Proposed combination between Essilor and Luxottica approved without conditions by the European Commission 53
Section 6 – Appendix 54
Methodology 54
Ratio Definitions 54
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Essilor International Compagnie Generale d'Optique SA, Key Facts 6
Essilor International Compagnie Generale d'Optique SA, Key Employees 7
Essilor International Compagnie Generale d'Optique SA, Key Employee Biographies 8
Essilor International Compagnie Generale d'Optique SA, Major Products and Services 9
Essilor International Compagnie Generale d'Optique SA, History 11
Essilor International Compagnie Generale d'Optique SA, Subsidiaries 16
Essilor International Compagnie Generale d'Optique SA, Joint Venture 22
Essilor International Compagnie Generale d'Optique SA, Key Competitors 32
Essilor International Compagnie Generale d'Optique SA, Ratios based on current share price 33
Essilor International Compagnie Generale d'Optique SA, Annual Ratios 34
Essilor International Compagnie Generale d'Optique SA, Annual Ratios (Cont...1) 35
Essilor International Compagnie Generale d'Optique SA, Annual Ratios (Cont...2) 36
Essilor International Compagnie Generale d'Optique SA, Interim Ratios 38
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 40
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Type, 2012 to YTD 2018 41
Essilor International Compagnie Generale d'Optique SA, Recent Deals Summary 42
Currency Codes 54
Capital Market Ratios 54
Equity Ratios 55
Profitability Ratios 55
Cost Ratios 56
Liquidity Ratios 56
Leverage Ratios 57
Efficiency Ratios 57

List of Figures
Essilor International Compagnie Generale d'Optique SA, Performance Chart (2013 - 2017) 37
Essilor International Compagnie Generale d'Optique SA, Ratio Charts 39
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 40
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 41

★海外企業調査レポート[Essilor International Compagnie Generale d’Optique SA (EI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Omnicom Group, Inc.:企業の戦略・SWOT・財務分析
    Omnicom Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Omnicom Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • SK Gas Co Ltd (018670):企業の財務・戦略的SWOT分析
    Summary SK Gas Co Ltd (SK Gas), a subsidiary of SK Chemicals Co Ltd, is an oil and gas company that supplies liquefied petroleum gas. It operates through its business divisions such as LPG marketing, global LPG trading, LPG import terminal, propane de-hydrogenation and tank terminal. It offers tank …
  • Genesis HealthCare Corp (GEN)-製薬・医療分野:企業M&A・提携分析
    Summary Genesis HealthCare Corp (Genesis HealthCare) is a healthcare company that provides nursing and rehabilitation therapy. The company offers services such as rehabilitation therapy, ventilator care, dialysis care, private duty home care, hospice care, respiratory health, post acute management a …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • AeroMaoz Ltd.:企業の戦略・SWOT・財務情報
    AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report Summary AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Inform Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inform Diagnostics Inc(Inform Diagnostics) formerly known as Miraca Life Sciences, a subsidiary of Miraca Holdings Inc, is an anatomic pathology laboratory that offers diagnostic services. The laboratory provides services in the areas of breast health, dermatology, gastroenterology, hematolo …
  • North Asia Strategic Holdings Limited:企業の戦略・SWOT・財務分析
    North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • State Bank Of India
    State Bank Of India - Strategy, SWOT and Corporate Finance Report Summary State Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Touchstone Group plc:企業の戦略的SWOT分析
    Touchstone Group plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ambu AS (AMBU B):医療機器:M&Aディール及び事業提携情報
    Summary Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, patient monitoring and diagnostics, and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The major products …
  • Carl Zeiss AG:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss AG (Carl Zeiss) is a medical technology with focus on optical and optoelectronic industry. It develops and distributes lithography optics, measuring technology, photomask systems, microscopes, medical technology products including ophthalmic diagnostic and therapeutic products, ey …
  • Gerresheimer AG:戦略・SWOT・企業財務分析
    Gerresheimer AG - Strategy, SWOT and Corporate Finance Report Summary Gerresheimer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Grupo Juste SAQF:製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Juste SAQF (Juste) is a developer and distributor of proprietary medicines and active pharmaceutical ingredients. The company offers oral and injectable radiological contrast media; diatrizoic acid, iothalamic acid, iohexol, iopamidol, iodixanol, MRI contrast agents, dihexazin, and oth …
  • Calytrix Technologies Pty Ltd.:企業の戦略・SWOT・財務情報
    Calytrix Technologies Pty Ltd. - Strategy, SWOT and Corporate Finance Report Summary Calytrix Technologies Pty Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Punjab National Bank (PNB):電力:M&Aディール及び事業提携情報
    Summary Punjab National Bank (PNB) offers retail and commercial banking, agricultural and international banking, and other financial services. Its retail and commercial banking portfolio offers credit and debit cards, corporate and retail loans, deposit services, cash management, and export and impo …
  • Enel Green Power SpA:電力:M&Aディール及び事業提携情報
    Summary Enel Green Power SpA (EGP) a subsidiary of Enel SpA, is an energy company that is involved in developing and operating renewable projects. It generates power from wind, biomass, geothermal, solar, and hydropower sources. The company also has interests in various power plants in under constru …
  • Denka Company Ltd:企業の戦略・SWOT・財務分析
    Denka Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Denka Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EpiVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EpiVax Inc (EpiVax) develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which ac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆